Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > MEDICAL BIOCHEMISTRY AND METABOLOMICS (110100) > Medical Biochemistry - Proteins and Peptides (incl. Medical Proteomics) (110106)"
|Up a level|
- Subjects classification (39339)
- Australian and New Zealand Standard Research Classification (39339)
Group by: Authors/Creators | Item Type
Number of items at this level: 12.
Bowden, Joshua C., Rintoul, Llewellyn, Bostrom, Thor E., Pope, James M., & Wentrup-Byrne, Edeline (2007) Prediction of bovine cartilage proteoglycan content using energy dispersive X-ray analysis or optical absorbance and a multivariate techniques-fourier transform infrared microspectroscopy model. In Kneipp, Katrin, Aroca, Ricardo, Kneipp, Harald, & Wentrup-Byrne, Edeline (Eds.) New approaches in biomedical spectroscopy. American Chemical Society, Washington, D.C., pp. 377-390.
Becherel, Olivier J., Yeo, Abrey J., Stellati, Alissa, Heng, Evelyn Y. H., Luff, John, Suraweera, Amila, et al. (2013) Senataxin plays an essential role with DNA damage response proteins in meiotic recombination and gene silencing. PLOS Genetics, 9(4), e1003435.
Broadbent, James, Walsh, Terry, & Upton, Zee (2010) Proteomics in chronic wound research: potentials in healing and health. Proteomics - Clinical Applications, 4(2), pp. 204-214.
Broszczak, Daniel, Stupar, Dario, Compay, Arnulf Lloyd Lucero, Sharma, Masti Venugopal Srihari, Parker, Tony J., Shooter, Gary K., et al. (2012) Biochemical profiling of proteins and metabolites in wound exudate from chronic wound environments. Wound Practice and Research, 20(2), pp. 62-72.
Lai, John & Batra, Jyotsna (2014) Speckle-type POZ protein mutations interrupt tumor suppressor function of speckle-type POZ protein in prostate cancer by affecting androgen receptor degradation. Asian Journal of Andrology. (In Press)
Newnham, Tanya, Hardikar, Winita, Allen, Katrina, Wellard, R. Mark, Hamilton, Charles, Angus, Peter, et al. (2007) Liver transplantation for Argininosuccinic aciduria: Clinical, biochemical and metabolic outcome. Liver Transplantation, 14(1), pp. 41-45.
Paik, Y.K., Graham, Janice, Jones, Mavis, McDonald, Fiona, Holmes, Christina, & Ozdemir, Vuril (2009) Interview with Dr. Young-Ki Paik, President of the Human Proteome Organization (HUPO): Pharmacoproteomics and the approaching wave of “Proteomics Diagnostics”. Current Pharmacogenomics and Personalized Medicine, 7(4), pp. 243-248.
Parker, Tony J., Sampson, Dayle L., Broszczak, Daniel, Chng, Yee Lin, Carter, Shea L., Leavesley, David I., et al. (2012) A fragment of the LG3 peptide of endorepellin is present in the urine of physically active mining workers : a potential marker of physical activity. PLoS ONE, 7(3), e33714.
Peters, Amelia, Buchanan, Grant, Ricciardelli,, Bianco-Miotto, Tina, Centenera,, Harris, Jonathan, et al. (2009) Androgen receptor inhibits estrogen receptor-A activity and is prognostic in breast cancer. Cancer Research, 69(15), pp. 6131-6140.
Speer, Runa, Wulfkuhle, Julia, Espina, Virginia, Aurajo, Robyn, Edmiston, Kirsten H., Liotta, Lance, et al. (2007) Development of reverse phase protein microarrays for clinical applications and patient-tailored therapy. Cancer Genomics and Proteomics, 4(3), pp. 157-164.
Van Lonkhuyzen, Derek R., Hollier, Brett G., Shooter, Gary K., Leavesley, David I., & Upton, Zee (2007) Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptors. Growth Factors, 25(5), pp. 295-308.
Wallace,, Harris, Jonathan, & Subramaniam, Nathan (2009) Functional analysis and theoretical modelling of ferroportin reveals clustering of mutations according to phenotype. Cancer Research, 298(1), pp. 75-84.